Stock listing

ALINT Stock Price, News, Filings & Events — Integragen Sa

Selected listing: ALINT · EURONEXT · EUR · FR

This page tracks Integragen Sa's ALINT:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALINT:EURONEXT. ALINT:EURONEXT is the stock-level entry point for investors researching Integragen Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Integragen Sa is a public company listed on the Euronext Paris under the ticker ALINT. Based in France, the company has a market capitalization of approximately €1.17 million. Integragen focuses on providing genomic analysis and bioinformatics services to advance research and healthcare solutions.

ALINT:EURONEXTEURFRUpdated September 5, 2026
Integragen Sa logo
Ticker
ALINT:EURONEXT
Asset type
Stock
Market cap
$1.4M
Sector
Health Services
Industry
Medical/Nursing Services
Exchange
EURONEXT
Currency
EUR

Integragen Sa ALINT:EURONEXT stock context

This page tracks Integragen Sa's ALINT:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALINT:EURONEXT. ALINT:EURONEXT is the stock-level entry point for investors researching Integragen Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Integragen Sa is a public company listed on the Euronext Paris under the ticker ALINT. Based in France, the company has a market capitalization of approximately €1.17 million. Integragen focuses on providing genomic analysis and bioinformatics services to advance research and healthcare solutions.

Latest news from Integragen Sa

All Integragen Sa news →

Research Integragen Sa

Alternate listings